| Market Cap | ₹67Cr |
| ROE | 4.59% |
| P/E Ratio(TTM) | 56.74 |
| EPS(TTM) | 0.50 |
| P/B Ratio | 2.59 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.22 |
| Book Value | 10.96 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
| Parent Organisation | Kabra Drugs Limited |
| Managing Director | N. ARAVIND |
| Founded | 1989 |
| BSE Symbol | 524322 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.93 | ||
| Ajanta Pharma | NA (0.00%) | 34.14 | ||
| Gland Pharma | NA (0.00%) | 35.02 | ||
| Eris Lifesciences | NA (0.00%) | 47.66 |